Buxus Sempervirens 1 X Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02236450) held by Dolisos Canada Inc., containing Buxus Sempervirens. Health Canada lists its status as Cancelled Post Market (status date 20 Apr 2006). Nexara Health has matched 2 registrations of Buxus Sempervirens across 1 other regulated market.
Health Canada registration
| DIN | 02236450 |
|---|---|
| Brand name | Buxus Sempervirens |
| Active ingredient | Buxus Sempervirens |
| Strength | 1 X |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 20 Apr 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Buxus Sempervirens registered in other markets
2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Buxus sempervirens | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Buxus sempervirens | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
See every manufacturer of Buxus Sempervirens worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Buxus Sempervirens (DIN 02236450) marketed in Canada?
No. Health Canada lists DIN 02236450 as Cancelled Post Market as of 20 Apr 2006.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Buxus Sempervirens registered outside Canada?
Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02236450, status date 2006-04-20; national medicine registries: EU national register. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02236450, status date 2006-04-20; national medicine registries: EU national register.
Health Canada Drug Product Database (DPD), DIN 02236450, status date 2006-04-20; national medicine registries: EU national register. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.